MARTINSRIED, Germany--(BUSINESS WIRE)--Proteros biostructures GmbH (‘Proteros’) announced today the expansion of its collaboration with OSI Pharmaceuticals, Inc. (‘OSI’) in the field of protein crystallography. Following the successful delivery of valuable high resolution protein-ligand-structures on multiple kinase targets under Proteros’ Gallery Structure mode with compounds supplied by OSI, Proteros will now provide also Gene-to-Structure services to OSI.